The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis

Patients with inflammatory bowel disease (IBD) present with reduced serum insulin-like growth factor I (IGF-I). Anti-inflammatory treatment with prednisolone or infliximab ameliorates symptoms and increases ci…

Source link

Related posts

Video Press Briefings Feature Abstract Authors and Renowned GI Experts Discussing Key Science Presented at the American College of Gastroenterology’s 80th Annual Meeting


FDA clears endoscopy platform for use at ambulatory surgery centers


5 stories you may have missed in July


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy